Therefore, we suggest that S100A11 promotes NSCLC chemoresistance by facilitating PLA2 inhibition, consequently blocking AA release, which leads to the suppression of ROS-dependent apoptotic signaling. This evidence concerns the gene S100A11 and non-small cell lung carcinoma.